LATEST EUROPEAN WEB SURVEY ON DRUGS FINDS CANNABIS AND ECSTASY USE MOST IMPACTED BY COVID-19 (NEWS RELEASE NO 1/2022) New survey results released today by the EU drugs agency (EMCDDA) reveal that cannabis and ecstasy use are the drug-consumption patterns most impacted by COVID-19 restrictions (1). The European Web Survey on Drugs found that, while herbal cannabis use…
COVID-19: IPC ISSUE NEW GUIDELINES FOR ANTI-DOPING TESTING New measures are in place to further protect the health of athletes as well as the Sample Collection Personnel Illustration: ⒸIPC In the wake of COVID-19 pandemic, the International Paralympic Committee (IPC) has adjusted its anti-doping testing program to ensure it is in line with the…
CORONAVIRUS NOT AN OPPORTUNITY FOR ATHLETES TO DOPE: WADA PRESIDENT Illustration: AFP/File / Fabrice COFFRINI Athletes should not think the coronavirus pandemic and disruptions to testing give them an excuse to dope, World Anti-Doping Agency (WADA) President Witold Bańka says. Athletes are fooling themselves if they think they can use the chaos caused…
WADA UPDATES ITS COVID-19 GUIDANCE FOR ANTI-DOPING ORGANIZATIONS The World Anti-Doping Agency (WADA) has issued updated guidance for Anti-Doping Organizations (ADOs) in light of the ongoing COVID-19 pandemic. Illustration: SAA WADA developed the guidance following consultation with ADOs, including National Anti-Doping Organizations (NADOs), International Federations and Major Event Organizations as well as other organizations, such as the…
WADA MONITORS INTEGRITY OF ANTI-DOPING TESTING WORLDWIDE IN LIGHT OF THE COVID-19 VIRUS Illustration: Oldham News The World Anti-Doping Agency (WADA) advised Anti-Doping Organizations (ADOs) worldwide of the Agency’s approach for monitoring the integrity of anti-doping testing in light of the Covid-19 virus; and called on ADOs to prioritize health and safety while…
